Financial Perspectives’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Buy |
2,422
+13
| +0.5% | +$632 | 0.04% | 209 |
|
|
2025
Q1 | $82.4K | Sell |
2,409
-13
| -0.5% | -$445 | 0.03% | 237 |
|
|
2024
Q4 | $95.3K | Hold |
2,422
| – | – | 0.03% | 225 |
|
|
2024
Q3 | $114K | Hold |
2,422
| – | – | 0.04% | 201 |
|
|
2024
Q2 | $131K | Hold |
2,422
| – | – | 0.05% | 173 |
|
|
2024
Q1 | $165K | Buy |
2,422
+120
| +5% | +$8.18K | 0.06% | 152 |
|
|
2023
Q4 | $144K | Hold |
2,302
| – | – | 0.06% | 164 |
|
|
2023
Q3 | $104K | Hold |
2,302
| – | – | 0.05% | 180 |
|
|
2023
Q2 | $129K | Buy |
2,302
+441
| +24% | +$24.8K | 0.06% | 159 |
|
|
2023
Q1 | $84.2K | Hold |
1,861
| – | – | 0.04% | 210 |
|
|
2022
Q4 | $75.7K | Sell |
1,861
-63
| -3% | -$2.56K | 0.04% | 208 |
|
|
2022
Q3 | $126K | Buy |
1,924
+149
| +8% | +$9.74K | 0.07% | 152 |
|
|
2022
Q2 | $108K | Hold |
1,775
| – | – | 0.06% | 165 |
|
|
2022
Q1 | $111K | Buy |
1,775
+80
| +5% | +$5.02K | 0.05% | 178 |
|
|
2021
Q4 | $128K | Sell |
1,695
-1,510
| -47% | -$114K | 0.06% | 154 |
|
|
2021
Q3 | $359K | Sell |
3,205
-51
| -2% | -$5.71K | 0.18% | 80 |
|
|
2021
Q2 | $527K | Sell |
3,256
-368,996
| -99% | -$59.7M | 0.26% | 65 |
|
|
2021
Q1 | $3.06M | Buy |
372,252
+370,465
| +20,731% | +$3.04M | 0.15% | 110 |
|
|
2020
Q4 | $274K | Buy |
1,787
+894
| +100% | +$137K | 0.16% | 92 |
|
|
2020
Q3 | $74.7K | Buy |
893
+589
| +194% | +$49.3K | 0.05% | 165 |
|
|
2020
Q2 | $22.3K | Hold |
304
| – | – | 0.02% | 259 |
|
|
2020
Q1 | $12.9K | Hold |
304
| – | – | 0.01% | 294 |
|
|
2019
Q4 | $18.5K | Buy |
+304
| New | +$18.5K | 0.01% | 267 |
|